Barbara Gisevius

1.2k total citations
16 papers, 329 citations indexed

About

Barbara Gisevius is a scholar working on Pathology and Forensic Medicine, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Barbara Gisevius has authored 16 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in Barbara Gisevius's work include Multiple Sclerosis Research Studies (6 papers), Peripheral Neuropathies and Disorders (4 papers) and Hereditary Neurological Disorders (3 papers). Barbara Gisevius is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Peripheral Neuropathies and Disorders (4 papers) and Hereditary Neurological Disorders (3 papers). Barbara Gisevius collaborates with scholars based in Germany, United States and Switzerland. Barbara Gisevius's co-authors include Aiden Haghikia, Sarah Hirschberg, Alexander Duscha, Ralf Gold, Megan G. Massa, José Sancho, Andrew A. Scholte, M. X. FitzGerald, Lisa Woodworth and Oleg Butovsky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Barbara Gisevius

15 papers receiving 325 citations

Peers

Barbara Gisevius

NEURO

IMMUN

PHYSI

PFM

Begoña Fernández-Díez Spain

Toru Koda Japan

Carolina Manganeli Polonio Brazil

Ella A. Zuiderwijk‐Sick Netherlands

Sun‐Hye Shin South Korea

Alanna G. Spiteri Australia

Laura Cubas-Núñez Spain

Phillip K. West Australia

Juan Feng China

Sue Ling Lim Australia

Begoña Fernández-Díez Spain

Barbara Gisevius

103 ×0.7

106 ×1.3

NEURO

111 ×1.5

IMMUN

43 ×0.7

PHYSI

74 ×1.3

PFM

Citations per year, relative to Barbara Gisevius Barbara Gisevius (= 1×) peers Begoña Fernández-Díez

Countries citing papers authored by Barbara Gisevius

Since Specialization

Citations

This map shows the geographic impact of Barbara Gisevius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Gisevius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Gisevius more than expected).

Fields of papers citing papers by Barbara Gisevius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Gisevius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Gisevius. The network helps show where Barbara Gisevius may publish in the future.

Co-authorship network of co-authors of Barbara Gisevius

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Gisevius. A scholar is included among the top collaborators of Barbara Gisevius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Gisevius. Barbara Gisevius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Benkert, Pascal, Anthony Seibert, Thomas Grüter, et al.. (2025). Serum Neurofilament Light Chain as a Biomarker for CIDP Diagnosis, Severity, and Treatment Outcome. Neurology Neuroimmunology & Neuroinflammation. 12(4). e200419–e200419. 1 indexed citations

Hirche, Frank, Barbara Gisevius, Ralf Gold, et al.. (2025). Oral supplementation with propionate is reflected in the serum of healthy individuals. Therapeutic Advances in Neurological Disorders. 18. 4233590843–4233590843.

Haase, Stefanie, Kristina Kuhbandner, Barbara Gisevius, et al.. (2024). Dietary galactose exacerbates autoimmune neuroinflammation via advanced glycation end product-mediated neurodegeneration. Frontiers in Immunology. 15. 1367819–1367819. 1 indexed citations

Gisevius, Barbara, et al.. (2024). Quality of life and tolerability of B-cell directed therapy of multiple sclerosis with ofatumumab in a patient-centered real-world observational study. Journal of Neurology. 271(9). 6080–6088. 5 indexed citations

Ulrich, Rainer G., Verian Bader, Konstanze F. Winklhofer, et al.. (2024). Modeling extrahepatic hepatitis E virus infection in induced human primary neurons. Proceedings of the National Academy of Sciences. 121(47). e2411434121–e2411434121. 4 indexed citations

Grüter, Thomas, Seray Demir, Barbara Gisevius, et al.. (2023). Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system. Proceedings of the National Academy of Sciences. 120(4). e2216941120–e2216941120. 31 indexed citations

Gisevius, Barbara, et al.. (2023). Über ein Jahr B-Zell-gerichtete Therapie mit Ofatumumab s.c.: erste Ergebnisse einer prospektiven, patientenzentrierten Real-world-Beobachtungsstudie. Der Nervenarzt. 94(10). 923–933. 1 indexed citations

Beyer, Léon, Thomas Grüter, Kalliopi Pitarokoili, et al.. (2023). Serum neurofilament light chain does not detect self‐reported treatment‐related fluctuations in chronic inflammatory demyelinating polyneuropathy. European Journal of Neurology. 31(1). e16023–e16023. 5 indexed citations

Hagan, Nellwyn, John L. Kane, Deepak Grover, et al.. (2020). CSF1R signaling is a regulator of pathogenesis in progressive MS. Cell Death and Disease. 11(10). 904–904. 95 indexed citations

10.

Schneider, Ruth, Barbara Bellenberg, Barbara Gisevius, et al.. (2020). Chitinase 3–like 1 and neurofilament light chain in CSF and CNS atrophy in MS. Neurology Neuroimmunology & Neuroinflammation. 8(1). 29 indexed citations

11.

Haghikia, Arash, Claudia Bang, Kristian Scherf, et al.. (2019). Elevated levels of miR-181c and miR-633 in the CSF of patients with MS. Neurology Neuroimmunology & Neuroinflammation. 6(6). e623–e623. 17 indexed citations

12.

Duscha, Alexander, et al.. (2019). Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis. Frontiers in Neurology. 10. 132–132. 1 indexed citations

13.

Gisevius, Barbara, Aiden Haghikia, & Sarah Hirschberg. (2019). Impact of Diet and the Gut Microbiome on Neurodegeneration and Regeneration in Neurological Disorders. 25(1). 39–47. 2 indexed citations

14.

Hirschberg, Sarah, Barbara Gisevius, Alexander Duscha, & Aiden Haghikia. (2019). Implications of Diet and The Gut Microbiome in Neuroinflammatory and Neurodegenerative Diseases. International Journal of Molecular Sciences. 20(12). 3109–3109. 88 indexed citations

15.

Massa, Megan G., Christina David, Stefanie Jörg, et al.. (2017). Testosterone Differentially Affects T Cells and Neurons in Murine and Human Models of Neuroinflammation and Neurodegeneration. American Journal Of Pathology. 187(7). 1613–1622. 32 indexed citations

16.

Massa, Megan G., Barbara Gisevius, Sarah Hirschberg, et al.. (2016). Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells. PLoS ONE. 11(5). e0155274–e0155274. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact